Tech Company Financing Transactions

Spinal Modulation Funding Round

Spinal Modulation secured a $30 million Series D funding round on 6/13/2011. Investors included De Novo Ventures, ePlanet Capital and InCube Ventures.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series D

De Novo Ventures

ePlanet Capital (Martin Dieck)

InCube Ventures (Mir Imran)

Johnson & Johnson Development Corporation (Rami Elghandour)

Kleiner Perkins Caufield & Byers (Dana Mead)

Medventure Associates

Proceeds Purpose
Proceeds from the financing will be used to conduct clinical trials both in the UnitedStates and internationally. Additionally, the company plans to commence commercializationoutside the United States in the near future.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
1135 O'Brien Dr.
Menlo Park, CA 94025
Email Address
The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
Spinal Modulation LinkedIn Company Profile
Social Media
Spinal Modulation Company Twitter Account
Company News
Spinal Modulation News
Spinal Modulation on Facebook
Spinal Modulation on YouTube

Management Team

Email & Social
Chief Executive Officer
David Wood
  David Wood LinkedIn Profile  David Wood Twitter Account  David Wood News  David Wood on Facebook
Chief Scientific Officer
Jeff Kramer
  Jeff Kramer LinkedIn Profile  Jeff Kramer Twitter Account  Jeff Kramer News  Jeff Kramer on Facebook
Chief Technical Officer
Lynn Elliott
  Lynn Elliott LinkedIn Profile  Lynn Elliott Twitter Account  Lynn Elliott News  Lynn Elliott on Facebook
VP - Marketing
Dan Brounstein
  Dan Brounstein LinkedIn Profile  Dan Brounstein Twitter Account  Dan Brounstein News  Dan Brounstein on Facebook
VP - Operations
Bob Gaffney
  Bob Gaffney LinkedIn Profile  Bob Gaffney Twitter Account  Bob Gaffney News  Bob Gaffney on Facebook
VP - Regulatory Affairs
Steven McQuillan
  Steven McQuillan LinkedIn Profile  Steven McQuillan Twitter Account  Steven McQuillan News  Steven McQuillan on Facebook
VP - Sales
Martin Chambers
  Martin Chambers LinkedIn Profile  Martin Chambers Twitter Account  Martin Chambers News  Martin Chambers on Facebook



Browse more venture capital transactions:

Prev: 6/13/2011: Agrivida venture capital transaction
Next: 6/13/2011: Proterra venture capital transaction


Share this article


Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary